The Valley Desk

NCT03338816 · Interventional trial

ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)

Overall registry status Completed

Phase 3

Conditions ALA Dehydratase Deficient Porphyria (ADP), Acute Hepatic Porphyria, Acute Intermittent Porphyria, Acute Porphyria, Hereditary Coproporphyria (HCP), Porphyria, Acute Intermittent, Variegate Porphyria (VP)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov